Tango Therapeutics (NasdaqGM:TNGX) 2026 Conference Transcript

Tango Therapeutics (NasdaqGM:TNGX) 2026 Conference March 11, 2026 03:00 PM ET Company ParticipantsMalte Peters - President and CEOConference Call ParticipantsAndrew Berens - Senior Research AnalystAndrew BerensAndrew Berens, Senior Biotech Analyst, Targeted Oncology at Leerink Partners. Very excited to have with us Tango Therapeutics, the CEO, Malte Peters. Thank you for joining us.Malte PetersThank you, Andy. Thanks Leerink for having us. We are excited to be here and share some updates on our end.Andrew B ...